Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis

BACKGROUND: Controversy exists as to whether the threshold for blood pressure-lowering treatment should differ between people with and without type 2 diabetes. We aimed to investigate the effects of blood pressure-lowering treatment on the risk of major cardiovascular events by type 2 diabetes statu...

Descripción completa

Detalles Bibliográficos
Autores principales: Nazarzadeh, Milad, Bidel, Zeinab, Canoy, Dexter, Copland, Emma, Bennett, Derrick A, Dehghan, Abbas, Davey Smith, George, Holman, Rury R, Woodward, Mark, Gupta, Ajay, Adler, Amanda I, Wamil, Malgorzata, Sattar, Naveed, Cushman, William C, McManus, Richard J, Teo, Koon, Davis, Barry R, Chalmers, John, Pepine, Carl J, Rahimi, Kazem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Lancet, Diabetes & Endocrinology 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622419/
https://www.ncbi.nlm.nih.gov/pubmed/35878651
http://dx.doi.org/10.1016/S2213-8587(22)00172-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622419/
https://www.ncbi.nlm.nih.gov/pubmed/35878651
http://dx.doi.org/10.1016/S2213-8587(22)00172-3

Ejemplares similares